Cargando…
Curative one-shot systemic virotherapy in murine myeloma
Current therapy for multiple myeloma is complex and prolonged. Antimyeloma drugs are combined in induction, consolidation and/or maintenance protocols to destroy bulky disease, then suppress or eradicate residual disease. Oncolytic viruses have the potential to mediate both tumor debulking and resid...
Autores principales: | Naik, Shruthi, Nace, Rebecca, Federspiel, Mark J., Barber, Glen N., Peng, Kah-Whye, Russell, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411853/ https://www.ncbi.nlm.nih.gov/pubmed/22425894 http://dx.doi.org/10.1038/leu.2012.70 |
Ejemplares similares
-
Mathematical Model for Radial Expansion and Conflation of Intratumoral Infectious Centers Predicts Curative Oncolytic Virotherapy Parameters
por: Bailey, Kent, et al.
Publicado: (2013) -
Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV
por: Yarde, Danielle N., et al.
Publicado: (2013) -
ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012) -
Reporter gene imaging identifies intratumoral infection voids as a critical barrier to systemic oncolytic virus efficacy
por: Miller, Amber, et al.
Publicado: (2014) -
Potent systemic therapy of Multiple Myeloma utilizing Oncolytic Vesicular stomatitis virus coding for Interferon-beta
por: Naik, Shruthi, et al.
Publicado: (2012)